WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current ...

For the study, they focused on the SARS-CoV-2 spike protein—the part of the virus responsible for helping it enter human cells—and used a protein language model to predict potential new ...

For the study, they focused on the SARS-CoV-2 spike protein – the part of the virus responsible for helping it enter human cells – and used a protein language model to predict potential new ...

From egg prices to pet food recalls – and now, confirmation that another strain of bird flu has infected a large commercial ...

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely ...

Researchers have shown a new drug compound can prevent long COVID symptoms in mice—a landmark finding that could lead to a ...

"Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants," an in vivo hamster model was used to evaluate the ...

Although Paxlovid did not demonstrate widespread efficacy, a novel approach to long COVID research has emerged.